Clinical Trial Update: A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing low-dose interferon alpha with hydroxyurea in chronic myeloid neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Interferon alpha (low-dose) (Interferon alpha)

Snippet

Sponsor: Thomas Stauffer Larsen | Conditions: Polycythemia Vera, Essential Thrombocythemia | Phase 3 | Status: COMPLETED